Medicinal chemistry lead optimization (phase 1) sbir topic 220

Ended Definitive Contract Awarded Last action

Contract number
HHSN261200622018C
Awardee
Awarding agency
Obligated
$99,961

Award facts

Contract value 50% obligated
$199,922.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
Not on record
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 3 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
North Brunswick Township, NJ 08902, USA
Research
SBIR Program Phase I Action

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 1 $0
Original award $99,961

About this award

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by a U.S. government agency to Provid Pharmaceuticals Inc., a for-profit organization, in the amount of $199,922.00. The contract is for "Medicinal Chemistry Lead Optimization" research, with a completion date of June 29, 2007. The contract is a Firm Fixed Price Definitive Contract, with the place of performance being North Brunswick Township, NJ.

Quick answers

Who was awarded contract HHSN261200622018C?

HHSN261200622018C was awarded to Provid Pharmaceuticals Inc. by National Cancer Institute (National Institutes of Health) on September 29, 2006.

How much is contract HHSN261200622018C worth?

The government has obligated $99,961 on HHSN261200622018C. Its current value, with exercised options, is $199,922.

Was contract HHSN261200622018C competed?

The extent of competition for HHSN261200622018C was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award